Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

TCS a Leader in Life Sciences Digital Services: Everest Group

Posted On: 2019-10-07 11:33:40


Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has been named a Leader in the Everest Group PEAK Matrix™ for Life Sciences Digital Services1.

The report analyzed the digital services capabilities of 23 IT service providers to the life sciences sector globally. It highlights TCS' credible digital transformation capabilities with scale and consistency of performance. Also cited as a key strength is the company's focus on next-generation digital solutions such as Advanced Drus Development (ADD) and Connected Clinical Trials leveraging artificial intelligence, smart analytics and IoT for drug development and patient engagement.

"Technologies such as AI and IoT are transforming the drug discovery and development value chain and helping life sciences companies accelerate their product innovation," said Debashis Ghosh, Business Group Head, Life Sciences and Healthcare, TCS. "Our consistent leadership positioning in various analyst assessments is a reflection of our vision, capability, innovation efforts and the resultant market success."

TCS partners with leading life sciences companies to enable their digital transformation journey by leveraging its Business 4.0™ framework and Machine First™ Delivery Model (MFDM™). TCS offers a full set of digital transformation services and solutions including advisory services, predictive and prescriptive analytics, genomics research, advanced platform solutions, digital content factory, digital marketing and cognitive business operations. Early investments in re-skilling the workforce, building agile workplaces, and developing intellectual property have helped TCS gain significant scale and depth in digital technologies.

TCS' experts in the life sciences domain work closely with solution architects to come up with innovative solutions that use a combination of user-friendly omnichannel front-end technologies, AI, IoT/wearables, big data, cognitive computing capabilities, RPA, blockchain and cloud to reimagine the life sciences value chain. The company's extensive portfolio of intellectual property - including the award-winning ADD platform, Decision Fabric™ engine, Real World Evidence platform, and Translational Research Platform - helps customers achieve better speed to market and superior business outcomes. Additionally, hosting thought leadership forums such as the ADDVantage Cross Pharma Meeting, has boosted TCS' standing in the life sciences industry.

"Challenges such as the complexity and high cost of drug development and increased time-to-market for drugs confront life sciences enterprises today. Additionally, the expectations from life sciences firms to advance the value-based care conversation is amplifying the focus on outcome-based contracting. To overcome these challenges, enterprises are prioritizing the adoption of digital technologies with a focus on scaling technology proliferation and core business outcomes. With its Machine First Delivery Model™ and its Business 4.0™ framework, TCS provides a structured approach to digital transformation, led by a focus on core products, innovation labs, and creative engagement models to help scale innovation," said Nitish Mittal, Vice President, Everest Group.

"With our contextual knowledge, a consistent successful record with digital use-cases, intellectual property, and co-innovation partners in the Life Sciences clinical eco-system, we drive our customers' Business 4.0™ journeys," added Debashis Ghosh.

Shares of TATA CONSULTANCY SERVICES LTD. was last trading in BSE at Rs.2080 as compared to the previous close of Rs. 2058.85. The total number of shares traded during the day was 44798 in over 3631 trades.

The stock hit an intraday high of Rs. 2087 and intraday low of 2054.75. The net turnover during the day was Rs. 93093638.

1 Life Sciences Digital Services - Service Provider Landscape with Services PEAK Matrix™ Assessment 2019, Abhishek Singh, Nitish Mittal, Chunky Satija, Pranav Kumar, Nisarg Shah, September 13, 2019


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Dishman Carbogen Amcis Ltd board to announce Q4, FY20 results on June 3, 2020

Raymond Ltd approves issue of NCDs aggregating Rs. 80 crore

Exide Industries Ltd board to consider Q4, FY20 results on June 5, 2020

Cosmo Films Ltd board to approve Q4, FY20 results on June 4, 2020

Hindustan Oil Exploration Company Ltd Q4 consolidated PAT falls to Rs. 11.58 crore

Multi Commodity Exchange of India Ltd Board approves dividend of Rs. 30

The Great Eastern Shipping Company Ltd reports loss of Rs. 50.68 crore in Q4 FY20

CreditAccess Grameen Ltd Q4 FY20 consolidated PAT slips to Rs. 28.84 crore

Amber Enterprises India Ltd Q4 consolidated PAT at Rs. 62.84 crore

Mercury Laboratories Ltd Q4 loss at Rs. 0.35 crore

Moody's downgrades India Infoline Finance Limited to B1 from Ba3, ratings remain under review for downgrade

Mercury Laboratories Ltd Board recommends Dividend of Rs. 2 for FY20

MCX Q4 consolidated net profit up at Rs. 65.50 crore

Lemon Tree Hotels Ltd board approves fund raising proposal

Amara Raja Batteries Ltd reports Q4 FY20 consolidated net profit of Rs. 137.30 crore

Seshasayee Paper and Boards Ltd board recommends dividend of Rs. 4

IDBI Bank Back in Black, registers Net Profit of Rs. 135 crore in Q4 FY 2020 after 13 Quarters

Polycab India Ltd reports Rs. 213.93 crore consolidated PAT in Q4 FY20

KEI Industries Ltd posts consolidated PAT of Rs. 62.03 crore in Q4 FY20

Seshasayee Paper and Boards Ltd Q4 FY20 consolidated PAT at Rs. 48.01 crore

The Great Eastern Shipping Company Ltd board declares interim dividend of Rs. 2.70

Kotak Mahindra Bank allots 6.5 crore shares at Rs. 1145 per share

Affle India Ltd Q4 consolidated PAT up YoY at Rs. 15.28 crore

Advanced Enzyme Technologies Ltd board recommends dividend of Rs. 0.60

RCF's Q4 2019-20 profit after tax rises over 190 % over Q4 2018-19

Eris Lifesciences Ltd board to consider Q4, FY20 results on June 2, 2020

Advanced Enzyme Technologies Ltd Q4 consolidated PAT at Rs. 31.33 crore

Kaveri Seed Company Ltd Q4 FY20 consolidated net profit at Rs. 7.57 crore

Kanpur Plastipack Ltd Board recommends final dividend of Rs. 0.60 for FY20

Techno Electric & Engineering Company Ltd to sell its stake in JKTPL

NLC India Limited raises Rs. 500 crore through Commercial Paper

Kanpur Plastipack Ltd Q4 PAT at Rs. 0.47 crore

CRISIL updates on rating of Jubilant Life Sciences Limited

KRBL Limited board to announce Q4, FY20 results on June 9, 2020

Sagar Cements Ltd reports Rs. 1.29 crore consolidated PAT in Q4 FY20

Procter & Gamble Health Ltd posts Rs. 46.46 crore PAT during the quarter ended March 31, 2020

Customer Service a Priority: Maruti Suzuki announces extension of free service and warranty

Suven Life Sciences Ltd board to consider Q4, FY20 results on June 5, 2020

Everest Industries Ltd Board recommends dividend of Rs. 1 for FY20

ESAF Small Finance Bank Profit Soars 110%

Lemon Tree Hotels Ltd Q4 FY20 loss at Rs. 17.91 crore

IndiGo announces the appointment of Dr. Venkataramani Sumantran as an Independent Director

Sundaram Finance FY20 Net Profit at Rs. 724 crores, revenues up 16% at Rs. 3842 crores

KPTL announces execution of share purchase agreement for divestment of stake in Jhajjar KT Transco Transmission Asset

YES Bank acquires 24.19% in Dish TV India Ltd through invocation of pledged shares

V-Mart reports 16% revenue growth and 61% increase in EBITDA y-o-y in FY20

India Ratings Maintains Union Bank of India on RWE

CRISIL assigns 'CRISIL AAA/Stable' Rating on Rs. 500 crores NonConvertible Debenture (NCD) Programme of M&M

SCI Q4 consolidated PAT at Rs. 111.05 crore

IndiGrid announces execution of share purchase agreement for acquisition of Jhajjar KT Transco Private Limited







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019